2022 · pending · EP4540391A2
Treatment of MS4A4E Related Diseases and Disorders
Gregory McInnes
MS4A4E inhibitors including oligonucleotides (siRNA or ASO) for the treatment of conditions associated with MS4A4E mutations.
RNA Therapeutics
2022 · pending · EP4540391A2
Gregory McInnes
MS4A4E inhibitors including oligonucleotides (siRNA or ASO) for the treatment of conditions associated with MS4A4E mutations.
RNA Therapeutics